Influx Healthtech Limited (NSE:INFLUX)
275.50
-4.75 (-1.69%)
At close: Nov 16, 2026
Influx Healthtech Revenue
Influx Healthtech had revenue of 854.15M INR in the half year ending September 30, 2026. This brings the company's total for the last twelve months to 1.65B, up 41.30% year-over-year. In the fiscal year ending March 31, 2026, Influx Healthtech had annual revenue of 1.47B with 40.04% growth. That makes Influx Healthtech the 34,623rd largest company in the world by revenue and 2,782nd in India.
Revenue (ttm)
1.65B
Revenue Growth
+41.30%
P/S Ratio
3.85
Revenue / Employee
5.95M
Employees
278
Market Cap
6.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.47B | 419.80M | 40.04% |
| Mar 31, 2025 | 1.05B | 48.89M | 4.89% |
| Mar 31, 2024 | 999.65M | 239.09M | 31.44% |
| Mar 31, 2023 | 760.57M | 168.55M | 28.47% |
| Mar 31, 2022 | 592.02M | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bajaj HealthCare | 6.56B |
| NGL Fine-Chem | 5.74B |
| Aarey Drugs & Pharmaceuticals | 4.20B |
| Resonance Specialties | 1.14B |
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.04B |
| Shree Ganesh Remedies | 919.58M |
| Accretion Nutraveda | 489.95M |